TIDMSTX TIDMSTXW

RNS Number : 2046Z

Shield Therapeutics PLC

13 March 2017

Shield Therapeutics plc

("Shield" or the "Group")

Notice of Results

London, UK, 13 March 2017: Shield Therapeutics plc (LSE:STX), a specialty pharmaceutical company focused on the development and commercialisation of late-stage pharmaceuticals that address unmet medical needs in secondary care, announces it will report its audited results for the year ended 31 December 2016 on Tuesday 4 April 2017.

CEO, Carl Sterritt, and members of the management team will host a presentation and live conference call for analysts at 9.30am BST on the morning of the results in the Guildhall Room at 85 Gresham Street, London, EC2V 7NQ.

- Ends -

For further information please contact:

 
 Shield Therapeutics plc                +44 (0)20 7186 8500 
 Carl Sterritt, Chief Executive 
  Officer 
 Nominated Adviser and Broker 
  Liberum Capital Limited 
  Christopher Britton/Steve 
  Pearce                                +44 (0)20 3100 2222 
 Financial PR Advisor                   +44 (0)20 3709 5700 
  Consilium Strategic Communications     shieldtherapeutics@consilium-comms.com 
 Mary-Jane Elliott/Matthew 
  Neal

About Shield Therapeutics plc

Shield Therapeutics is a specialty pharmaceutical company focused on the commercialisation and development of late-stage, hospital-focused pharmaceuticals which address areas of unmet medical need. The Group has a marketed product, Feraccru(R), for the treatment of iron deficiency anaemia (IDA) in adult patients with inflammatory bowel disease (IBD) which has exclusive IP rights until 2034. In addition, the Group is developing PT20, a late-stage pharmaceutical for the treatment of systemic phosphate accumulation (hyperphosphatemia). Shield Therapeutics, headquartered in London, is listed on LSE's AIM under the ticker STX. For more information please visit www.shieldtx.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBRGDXUXBBGRG

(END) Dow Jones Newswires

March 13, 2017 03:01 ET (07:01 GMT)

Shield Therapeutics (LSE:STX)
Historical Stock Chart
From May 2024 to May 2024 Click Here for more Shield Therapeutics Charts.
Shield Therapeutics (LSE:STX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Shield Therapeutics Charts.